Stockscreener 앱 받기
33.07
6.88%
2.13
시간 외 거래:
33.10
0.03
+0.09%
전일 마감가:
$30.94
열려 있는:
$31.13
하루 거래량:
2.02M
Relative Volume:
2.48
시가총액:
$2.52B
수익:
-
순이익/손실:
$-64.16M
주가수익비율:
-26.04
EPS:
-1.2702
순현금흐름:
$-69.06M
1주 성능:
+23.30%
1개월 성능:
+22.75%
6개월 성능:
+23.26%
1년 성능:
-11.95%
1일 변동 폭
$29.85
$33.73
1주일 범위
$26.25
$33.73
52주 변동 폭
$14.80
$40.47
Cg Oncology Inc Stock (CGON) Company Profile
명칭
Cg Oncology Inc
전화
(949) 419-6203
주소
400 SPECTRUM CENTER DRIVE, IRVINE
CGON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
33.07 | 2.36B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-07-10 | 재개 | Goldman | Buy |
| 2025-05-02 | 개시 | JP Morgan | Overweight |
| 2025-04-16 | 개시 | Scotiabank | Sector Perform |
| 2025-01-07 | 개시 | TD Cowen | Buy |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-09-23 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-28 | 개시 | ROTH MKM | Buy |
| 2024-06-28 | 개시 | BofA Securities | Buy |
| 2024-02-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-20 | 개시 | Goldman | Neutral |
| 2024-02-20 | 개시 | Morgan Stanley | Overweight |
| 2024-02-14 | 개시 | H.C. Wainwright | Buy |
모두보기
Cg Oncology Inc 주식(CGON)의 최신 뉴스
What are CG Oncology Inc.’s technical support levels2025 Short Interest & Community Verified Swing Trade Signals - خودرو بانک
CG Oncology reports 41.8% complete response rate at 24 months for bladder cancer drug - Investing.com Canada
Understanding CG Oncology Inc.’s price movementQuarterly Profit Report & Technical Entry and Exit Tips - Newser
Will CG Oncology Inc. outperform the marketTrade Analysis Report & Consistent Profit Focused Trading Strategies - Newser
Is CG Oncology Inc. a candidate for recovery playTrade Volume Report & Real-Time Volume Surge Alerts - Newser
Updated BOND-003 data support durability of cretostimogene grenadenorepvec in NMIBC - Urology Times
CG Oncology stock rises on strong bladder cancer treatment durability data - Investing.com Australia
CG Oncology Says Investigational Bladder Cancer Drug Shows 'Robust' Response - MarketScreener
CG Oncology Reports 41.8% Complete Response Rate for Cretostimogene in High-Risk Bladder Cancer Patients Unresponsive to BCG Treatment - Quiver Quantitative
41.8% Complete Response: CG Oncology's Breakthrough Bladder Cancer Drug Shows Best-in-Disease Durability - Stock Titan
Song Hong Fang, CG Oncology director, sells $2.78m in shares - Investing.com Canada
Can CG Oncology Inc. withstand a market correctionJuly 2025 Rallies & Fast Moving Stock Trade Plans - خودرو بانک
Visualizing CG Oncology Inc. stock with heatmapsPortfolio Gains Report & Real-Time Volume Spike Alerts - Newser
Chart based exit strategy for CG Oncology Inc.Weekly Loss Report & Verified Momentum Watchlists - Newser
Detecting support and resistance levels for CG Oncology Inc.July 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
CG Oncology Directors Sell Shares, Buy Others Amid Market Volatility. - AInvest
How does CG Oncology Inc. score in quality rankingsEarnings Growth Summary & Daily Chart Pattern Signal Reports - خودرو بانک
Risk On: Can CG Oncology Inc. deliver alphaJuly 2025 Volume & Daily Chart Pattern Signals - خودرو بانک
What moving averages say about CG Oncology Inc.July 2025 Final Week & Free Expert Approved Momentum Trade Ideas - Newser
Will CG Oncology Inc. stock go up soonShort Setup & Real-Time Volume Triggers - Newser
Real time breakdown of CG Oncology Inc. stock performance - Newser
CG Oncology Inc. stock chart pattern explained2025 Biggest Moves & Long-Term Investment Growth Plans - Newser
Ani Pharmaceuticals shares rise 1.98% after-hours following CG Oncology's PIVOT-006 study enrollment completion. - AInvest
Will CG Oncology Inc. benefit from macro trendsSwing Trade & Accurate Intraday Trading Signals - Newser
CG Oncology Completes Enrollment for Phase 3 Study - Orange County Business Journal
CG Oncology completes enrollment for bladder cancer therapy trial - Investing.com
CG Oncology completes enrollment in PIVOT-006 - TipRanks
CG Oncology Completes Rapid Enrollment in Phase 3 Study for Intermediate-Risk Non-Muscle Invasive Bladder Cancer - Quiver Quantitative
CG Oncology Completes Enrollment in PIVOT-006 Trial for Intermediate-Risk Non-Muscle Invasive Bladder Cancer - AInvest
Largest-Ever Trial: 360 Patients Join CG Oncology's Breakthrough Bladder Cancer Study One Year Early - Stock Titan
Using economic indicators to assess CG Oncology Inc. potentialMarket Activity Recap & Entry Point Confirmation Signals - Newser
Real time alert setup for CG Oncology Inc. performanceJuly 2025 Momentum & Daily Profit Focused Screening - Newser
Developing predictive dashboards with CG Oncology Inc. data2025 Retail Activity & Real-Time Volume Triggers - Newser
How to build a custom watchlist for CG Oncology Inc.Market Movement Recap & Community Supported Trade Ideas - Newser
Analyzing CG Oncology Inc. with risk reward ratio chartsTrade Performance Summary & AI Powered Buy/Sell Recommendations - Newser
Should you hold or exit CG Oncology Inc. nowEntry Point & Free Verified High Yield Trade Plans - Newser
Published on: 2025-09-03 00:18:12 - Newser
Can CG Oncology Inc. sustain earnings growthWeekly Earnings Recap & Long-Term Safe Investment Plans - خودرو بانک
Is CG Oncology Inc. stock reversal real or fakeBear Alert & Low Risk High Reward Trade Ideas - Newser
Technical signs of recovery in CG Oncology Inc.Quarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - Newser
Using flow based indicators on CG Oncology Inc.2025 Price Momentum & Consistent Growth Stock Picks - Newser
Is CG Oncology Inc. still worth holding after the dipQuarterly Performance Summary & Verified Chart Pattern Trade Signals - Newser
Can CG Oncology Inc. deliver alphaJuly 2025 Market Mood & Breakout Confirmation Trade Signals - خودرو بانک
CG Oncology Inc. stock trend forecastForecast Cut & AI Driven Stock Movement Reports - Newser
Can CG Oncology Inc. hit a new high this monthTrade Entry Summary & Low Risk Entry Point Tips - Newser
Chart based analysis of CG Oncology Inc. trendsJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser
What is the target price for CG Oncology Inc. stockJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - خودرو بانک
Cg Oncology Inc (CGON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cg Oncology Inc 주식 (CGON) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Song Hong Fang | Director |
Sep 03 '25 |
Sale |
27.80 |
100,000 |
2,779,542 |
2,903,931 |
| POST LEONARD E | Director |
Sep 03 '25 |
Option Exercise |
0.60 |
1,000 |
600 |
1,000 |
| POST LEONARD E | Director |
Sep 03 '25 |
Sale |
28.00 |
1,000 |
28,000 |
0 |
1.40%
자본화:
|
볼륨(24시간):